1. 2748 Assessment of associations between disease stage and toxicity with bevacizumab (BEV) in ICON7, a phase III trial of front-line carboplatin/paclitaxel (CP) ± BEV for ovarian cancer (OC). (September 2015) Authors: Embleton, A.C.; Perren, T.J.; Cook, A.; Kent, E.; Pfisterer, J.; Ledermann, J.A.; Pujade-Lauraine, E.; Kristensen, G.; Beale, P.; Cervantes, A.; Farrelly, L.; Kaplan, R.; Parmar, M. K.B.; Oza, A.M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 6-Shogaol and mycophenolic acid are seen to act synergistically in combination with platinum drug in killing ovarian cancer cells. (December 2016) Authors: Anwar, M.S.; Yu, J.Q.; Beale, P.; Huq, F. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Doctor‐to‐doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctors. Issue 9 (September 2015) Authors: Moth, E. B; Parry, J.; Stockler, M. R; Beale, P.; Blinman, P.; Della‐Fiorentina, S.; Kiely, B. E Journal: Internal medicine journal Issue: Volume 45:Issue 9(2015) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Innovation in implementation: A new model of nutrition care for patients with head and neck cancer improves outcomes. (September 2018) Authors: Findlay, M.; Rankin, N.; Shaw, T.; White, K.; Boyer, M.; Milross, C.; De Abreu Lourenço, R.; Brown, C.; Coll, J.; Beale, P.; Bauer, J. Journal: Clinical nutrition Issue: Volume 37(2018)Supplement 1 Page Start: S197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Novel palladiums alone and in combination with phytochemicals in search of affordable chemotherapy. (December 2016) Authors: Alam, M.N.; Qing, J.Y.; Beale, P.; Chan, C.; Huq, F. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study. Issue 2 (1st February 2007) Authors: Harnett, P.; Buck, M.; Beale, P.; Goldrick, A.; Allan, S.; Fitzharris, B.; De Souza, P.; Links, M.; Kalimi, G.; Davies, T.; Stuart-Harris, R. Journal: International journal of gynecological cancer Issue: Volume 17:Issue 2(2007) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The impact of COVID-19 on cancer patients, their carers and oncology health professionals: A qualitative study. Issue 7 (July 2022) Authors: Butow, P.; Havard, PE; Butt, Z.; Juraskova, ; Sharpe, L.; Dhillon, H.; Beatty, L.; Beale, P.; Cigolini, M.; Kelly, B.; Chan, RJ; Kirsten, L.; Best, M.; Shaw, J. Journal: Patient education and counseling Issue: Volume 105:Issue 7(2022) Page Start: 2397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Use of palliative chemotherapy in patients aged 80 years and over with incurable cancer: experience at three Sydney cancer centres. Issue 1 (January 2017) Authors: Ip, E.; Pokorny, A. M. J.; Della‐Fiorentina, S.; Beale, P.; Bray, V.; Kiely, B. E.; Blinman, P. Journal: Internal medicine journal Issue: Volume 47:Issue 1(2017) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗